高级搜索
术前静脉术中腹腔化疗对胃癌手术影响的观察[J]. 肿瘤防治研究, 2001, 28(06): 471-472. DOI: 10.3971/j.issn.1000-8578.475
引用本文: 术前静脉术中腹腔化疗对胃癌手术影响的观察[J]. 肿瘤防治研究, 2001, 28(06): 471-472. DOI: 10.3971/j.issn.1000-8578.475
Influence of Preo perative Intra venous and Intra operative Intra peritoneal Chemotherapy on The Operation for Advanced Gastric Carcinoma[J]. Cancer Research on Prevention and Treatment, 2001, 28(06): 471-472. DOI: 10.3971/j.issn.1000-8578.475
Citation: Influence of Preo perative Intra venous and Intra operative Intra peritoneal Chemotherapy on The Operation for Advanced Gastric Carcinoma[J]. Cancer Research on Prevention and Treatment, 2001, 28(06): 471-472. DOI: 10.3971/j.issn.1000-8578.475

术前静脉术中腹腔化疗对胃癌手术影响的观察

Influence of Preo perative Intra venous and Intra operative Intra peritoneal Chemotherapy on The Operation for Advanced Gastric Carcinoma

  • 摘要: 目的 观察术前静脉化疗和术中腹腔化疗是否会延误手术时机, 增加手术危险和术后并发症以及对术后恢复的影响。方法 对入院的进展期胃癌患者, 在控制对观察结果影响较大因素的条件下, 按入院顺序分为观察及对照两组比较。观察组术前静脉、术中腹腔用MMC、5 -Fu、CF(甲酰四氢叶酸钙 )化疗。对照组术前、术中不给化疗。记录术前住院日, 术中失血、输血量和术后恢复情况, 观察化疗的毒副作用。结果 观察组术前化疗后 2 4例出现毒副反应。术前住院日, 术中失血、输血量, 术后并发症和恢复情况, 两组间无显著差异。结论 选用适当药物、剂量和疗程, 术前静脉和术中腹腔化疗不延误手术时机, 是安全可行的, 但需严密监测化疗药物的毒副作用, 采取相应的防治措施。

     

    Abstract: Objective To observe whether preoperative intravenous(IV)and intraoperative intraperitoneal(IP)chemotherapy delays operative timing, increases operative risk and postoperative complications and interferes with postoperative recovery. Methods patients were divided into two groups allording to admission order from August 1997 to October 1999 on the premise of matching some factors obviously interfering with observation results. In observation group MMC?5-Fu?CF were infused intravenously before operation. In c...

     

/

返回文章
返回